PHARMACIERGE_TECHNOLOGY_L - Accounts

Company Registration No. 09524503 (England and Wales)
PHARMACIERGE TECHNOLOGY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2020
PAGES FOR FILING WITH REGISTRAR
PHARMACIERGE TECHNOLOGY LIMITED
COMPANY INFORMATION
Directors
Mr L A Ungar
Mr E G Ungar
Mr R D L Ungar
(Appointed 14 July 2020)
Secretary
Mr E G Ungar
Company number
09524503
Registered office
3rd Floor
Hathaway House
Popes Drive
London
N3 1QF
Accountants
F M C B
3rd Floor Hathaway House
Popes Drive
Finchley
London
N3 1QF
Business address
Lower Ground Floor
8 Wimpole Street
London
W1G 9SP
Bankers
HSBC Bank plc
Lion House
25 Islington High Street
London
N1 9LJ
PHARMACIERGE TECHNOLOGY LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
PHARMACIERGE TECHNOLOGY LIMITED
BALANCE SHEET
AS AT 30 SEPTEMBER 2020
30 September 2020
- 1 -
2020
2019
Notes
£
£
£
£
Current assets
Debtors
3
52,966
76,075
Cash at bank and in hand
507,669
698
560,635
76,773
Creditors: amounts falling due within one year
4
(1,059,294)
(412,810)
Net current liabilities
(498,659)
(336,037)
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
(498,660)
(336,038)
Total equity
(498,659)
(336,037)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 September 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 30 June 2021 and are signed on its behalf by:
Mr R D L Ungar
Director
Company Registration No. 09524503
PHARMACIERGE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2020
- 2 -
1
Accounting policies
Company information

Pharmacierge Technology Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3rd Floor, Hathaway House, Popes Drive, Finchley, London, N3 1QF.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate support from its other group companies to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.4
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

PHARMACIERGE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2020
1
Accounting policies
(Continued)
- 3 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences that have originated but not reversed at the balance sheet date.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2020
2019
Number
Number
Total
-
0
-
0
3
Debtors
2020
2019
Amounts falling due within one year:
£
£
Corporation tax recoverable
46,856
55,394
Other debtors
6,110
20,681
52,966
76,075
4
Creditors: amounts falling due within one year
2020
2019
£
£
Trade creditors
58,476
4,085
Amounts owed to group undertakings
1,000,018
408,025
Other creditors
800
700
1,059,294
412,810
5
Parent company

The company is a wholly owned subsidiary of Pharmacierge Group Limited, a company registered in England and Wales and its registered office is 3rd Floor, Hathaway House, Popes Drive, London, N3 1QF.

The ultimate controlling party is Pharmacierge Group Limited.

2020-09-302019-10-01false30 June 2021CCH SoftwareCCH Accounts Production 2021.100No description of principal activityMr L A UngarMr R D L UngarMr R D L UngarMr E G Ungar095245032019-10-012020-09-3009524503bus:Director12019-10-012020-09-3009524503bus:CompanySecretaryDirector12019-10-012020-09-3009524503bus:Director22019-10-012020-09-3009524503bus:CompanySecretary12019-10-012020-09-3009524503bus:Director32019-10-012020-09-3009524503bus:RegisteredOffice2019-10-012020-09-3009524503bus:Agent12019-10-012020-09-30095245032020-09-30095245032019-09-3009524503core:CurrentFinancialInstrumentscore:WithinOneYear2020-09-3009524503core:CurrentFinancialInstrumentscore:WithinOneYear2019-09-3009524503core:CurrentFinancialInstruments2020-09-3009524503core:CurrentFinancialInstruments2019-09-3009524503core:ShareCapital2020-09-3009524503core:ShareCapital2019-09-3009524503core:RetainedEarningsAccumulatedLosses2020-09-3009524503core:RetainedEarningsAccumulatedLosses2019-09-30095245032018-10-012019-09-3009524503core:WithinOneYear2020-09-3009524503core:WithinOneYear2019-09-3009524503bus:PrivateLimitedCompanyLtd2019-10-012020-09-3009524503bus:SmallCompaniesRegimeForAccounts2019-10-012020-09-3009524503bus:FRS1022019-10-012020-09-3009524503bus:AuditExemptWithAccountantsReport2019-10-012020-09-3009524503bus:FullAccounts2019-10-012020-09-30xbrli:purexbrli:sharesiso4217:GBP